Tiotropium bromide is a new quaternary ammonium compound with anticholinergic properties specific for muscarinic receptors (M1, M2, and M3) in humans. [1] Because acetylcholine modulates bronchial ...

September 20, 2010 (Barcelona, Spain) — Adding the anticholinergic agent tiotropium bromide (Spiriva, Boehringer-Ingelheim and Pfizer), approved for the treatment of chronic obstructive pulmonary ...

Vectura Group plc (LSE: VEC) ("Vectura", "the Group"), an industry-leading device and formulation business for inhaled airways products, today announces it is progressing the development of a branded ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Lupin’s 18 µg capsules of tiotropium bromide inhalation powder, according to a manufacturer ...

Details concerning the Tiotropium Bromide combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...

A study of 2 chronic obstructive pulmonary disease (COPD) inhalers from the same company was published recently in The Lancet Respiratory Medicine. The DYNAGITO trial showed tiotropium bromide and ...

In addition to the new exacerbation data, the indication for Stiolto Respimat has been revised. The Food and Drug Administration (FDA) has approved updated labeling for Stiolto Respimat (tiotropium ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Tiotropium Bromide Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Tiotropium Bromide, developed by ...

Research and Markets (http://www.researchandmarkets.com/research/rvchgj/investigation) has announced the addition of the "Investigation Report on China Tiotropium ...